Curist Allergy Relief Tablet
NDC Package 72559-021-48
Package Information
Curist Allergy Relief (levocetirizine dihydrochloride 5 mg) tablets is levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. This formulation utilizes a tablet delivery system. Marketed by Little Pharma, Inc., this product is identified by NDC 72559-021 and is authorized under FDA application ANDA213513.
Identification & Billing
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG Oral Tablet
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Oral - Administration to or by way of the mouth.
Regulatory & Marketing
Hierarchy Structure
- 72559 - Little Pharma, Inc.
- 72559-021 - Curist Allergy Relief
- 72559-021-48 - 365 TABLET in 1 BOTTLE
- 72559-021 - Curist Allergy Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72559-021). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72559-021-48 identifies a specific commercial package of 365 tablet in 1 bottle of Curist Allergy Relief, a human over the counter drug labeled by Little Pharma, Inc.. This tablet is formulated for oral use and contains levocetirizine dihydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Little Pharma, Inc. on January 24, 2023. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. It is also used to relieve itching and hives. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Levocetirizine does not prevent hives or prevent/treat a serious allergic reaction (such as anaphylaxis). If your doctor has prescribed epinephrine to treat allergic reactions, always carry your epinephrine injector with you. Do not use levocetirizine in place of your epinephrine.
How is this Little Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72559002148. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
